Clinical Trial: A Multicenter, Open-Label, Randomized Controlled Trial to Evaluate the Effect of Concomitant Oral Budesonide MMX on Treatment Outcomes in Ulcerative Colitis (Japan)

Tokyo, March 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060928) titled 'A Multicenter, Open-Label, Randomized Controlled Trial to Evaluate the Effect of Concomitant Oral Budesonide MMX on Treatment Outcomes in Ulcerative Colitis' on March 13.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Open -no one is blinded Control - Active

Primary Sponsor: Institute - Kobe University

Condition: Condition - ulcerative colitis Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate whether the addition of oral budesonide MMX to 5-aminosalicylic acid (5-ASA) therapy improves early treatm...